In this study, the levels of both anti-COPT1-IgG and anti-COPT1-IgM autoantibodies in NSCLC, BPN and NC were detected by ELISA, and combined with the traditional tumor marker CEA to evaluate the diagnostic value. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.